Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Miller

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 9, 2010
Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: aryl substituted pyrazole as a surrogate for the pyrazolopyridine motifDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
British Journal of Sports Medicine|September 5, 2020
Infographic. Clinical recommendations for return to play during the COVID-19 pandemicHerbert Löllgen, Norbert Bachl, Theodora Papadopoulou, et al.
BMJ Open Sport & Exercise Medicine|June 30, 2021
Recommendations for return to sport during the SARS-CoV-2 pandemicHerbert Löllgen, Norbert Bachl, Theodora Papadopoulou, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutantsDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Sports Medicine - Open|March 15, 2021
Recommendations for Face Coverings While Exercising During the COVID-19 PandemicJonathan Shurlock, Borja Muniz-Pardos, Ross Tucker, et al.
British Journal of Sports Medicine|July 17, 2021
Protecting olympic participants from COVID-19: the trialled and tested processFabio Pigozzi, Bernd Wolfarth, Ana Cintron Rodriguez, et al.
BMJ Open Sport & Exercise Medicine|February 7, 2022
Joint position statement of the International Federation of Sports Medicine (FIMS) and European Federation of Sports Medicine Associations (EFSMA) on the IOC framework on fairness, inclusion and non-discrimination based on gender identity and sex variationsFabio Pigozzi, Xavier Bigard, Juergen Steinacker, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding GroupChristopher J Bungard, Peter D Williams, Jeanine E Ballard, et al.
Sports Medicine (Auckland, N.Z.)|March 24, 2021
Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus StatementBlair R Hamilton, Giscard Lima, James Barrett, et al.
Sports Medicine (Auckland, N.Z.)|April 9, 2021
Correction to: Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus StatementBlair R Hamilton, Giscard Lima, James Barrett, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|July 9, 2010
Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: aryl substituted pyrazole as a surrogate for the pyrazolopyridine motifDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
British Journal of Sports Medicine|September 5, 2020
Infographic. Clinical recommendations for return to play during the COVID-19 pandemicHerbert Löllgen, Norbert Bachl, Theodora Papadopoulou, et al.
BMJ Open Sport & Exercise Medicine|June 30, 2021
Recommendations for return to sport during the SARS-CoV-2 pandemicHerbert Löllgen, Norbert Bachl, Theodora Papadopoulou, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutantsDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Sports Medicine - Open|March 15, 2021
Recommendations for Face Coverings While Exercising During the COVID-19 PandemicJonathan Shurlock, Borja Muniz-Pardos, Ross Tucker, et al.
British Journal of Sports Medicine|July 17, 2021
Protecting olympic participants from COVID-19: the trialled and tested processFabio Pigozzi, Bernd Wolfarth, Ana Cintron Rodriguez, et al.
BMJ Open Sport & Exercise Medicine|February 7, 2022
Joint position statement of the International Federation of Sports Medicine (FIMS) and European Federation of Sports Medicine Associations (EFSMA) on the IOC framework on fairness, inclusion and non-discrimination based on gender identity and sex variationsFabio Pigozzi, Xavier Bigard, Juergen Steinacker, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding GroupChristopher J Bungard, Peter D Williams, Jeanine E Ballard, et al.
Sports Medicine (Auckland, N.Z.)|March 24, 2021
Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus StatementBlair R Hamilton, Giscard Lima, James Barrett, et al.
Sports Medicine (Auckland, N.Z.)|April 9, 2021
Correction to: Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus StatementBlair R Hamilton, Giscard Lima, James Barrett, et al.
Pageof 4